// App-Quantinova.ai

TCT-163 : Do Patients with Paroxysmal Atrial Fibrillation in Sinus Rhythm during PCI Require Triple Therapy? Results from a Multicenter Center Study

Researchers

Presenter

  • Marco G. Mennuni

Principal Investigators

  • Kleanthis Theodoropoulos

  • Roxana Mehran

  • Chiara Bernelli

  • Antonio Colombo

  • Pedro R. Moreno

  • Prakash Krishnan

  • Jason Kovacic

  • Usman Baber

  • Jonathan L. Halperin

Medical Centers

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Mount Sinai School of Medicine, New York, NY

  • Mount Sinai School of Medicine, New York, NY

  • Mount Sinai Medical Center, New York, NY

  • Mount Sinai Medical Center, New York, NY

  • Cardiovascular Institute, Mount Sinai Medical Center, New York, USA, New York City, NY

  • N/A, New York, New York

  • Mount Sinai Hospital, New York, NY

  • Mount Sinai, New York, New York, NY

  • EMO GVM Centro Cuore Columbus/San Raffaele Hospital, Milan, Italy

  • Mount Sinai Medical Center, New York, NY

  • Istituto Clinico Humanitas IRCCS, Rozzano (Milan), Italy

  • San Raffaele Scientific Institute, Milan, Italy

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Arrhythmia

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved